- Home
- IRWD vs SMTI Comparison
IRWD vs SMTI Comparison
Compare IRWD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- SMTI
- Stock Information
- Founded
- IRWD 1998
- SMTI 1982
- Country
- IRWD United States
- SMTI United States
- Employees
- IRWD N/A
- SMTI N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- IRWD Health Care
- SMTI Health Care
- Exchange
- IRWD Nasdaq
- SMTI Nasdaq
- Market Cap
- IRWD 251.8M
- SMTI 251.6M
- IPO Year
- IRWD 2010
- SMTI N/A
- Fundamental
- Price
- IRWD $2.03
- SMTI $27.54
- Analyst Decision
- IRWD Buy
- SMTI Strong Buy
- Analyst Count
- IRWD 5
- SMTI 2
- Target Price
- IRWD $4.94
- SMTI $50.00
- AVG Volume (30 Days)
- IRWD 1.4M
- SMTI 23.8K
- Earning Date
- IRWD 11-04-2025
- SMTI 11-12-2025
- Dividend Yield
- IRWD N/A
- SMTI N/A
- EPS Growth
- IRWD N/A
- SMTI N/A
- EPS
- IRWD N/A
- SMTI N/A
- Revenue
- IRWD $308,519,000.00
- SMTI $97,241,894.00
- Revenue This Year
- IRWD N/A
- SMTI $24.49
- Revenue Next Year
- IRWD N/A
- SMTI $14.43
- P/E Ratio
- IRWD N/A
- SMTI N/A
- Revenue Growth
- IRWD N/A
- SMTI 34.29
- 52 Week Low
- IRWD $0.53
- SMTI $23.53
- 52 Week High
- IRWD $5.13
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- IRWD 68.00
- SMTI 37.29
- Support Level
- IRWD $1.76
- SMTI $28.30
- Resistance Level
- IRWD $2.23
- SMTI $29.39
- Average True Range (ATR)
- IRWD 0.16
- SMTI 1.20
- MACD
- IRWD 0.04
- SMTI -0.21
- Stochastic Oscillator
- IRWD 75.43
- SMTI 23.77
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.